Page 191 - Read Online
P. 191

Page 8 of 8                                          Vakhtangadze et al. Vessel Plus 2019;3:19  I  http://dx.doi.org/10.20517/2574-1209.2019.07

               47.  Merck. Merck Manual 2018. https://www.merckmanuals.com/professional
               48.  Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, et al. Hypertensive pregnancy disorders and subsequent cardiovascular
                   morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944-51.
               49.  Levine RJ, Vatten LJ, Horowitz GL, Qian C, Romundstad PR, et al. Karumanc pre-eclampsia, soluble fms-like tyrosine kinase 1, and
                   the risk of reduced thyroid function: nested case-control and population based study. BMJ 2009;17:39.
               50.  Hubel CA, Snaedal S, Ness RB, Weissfeld LA, Geirsson RT, et al. Dyslipoproteinaemia in postmenopausal women with a history of
                   eclampsia. BJOG 2000;107:776-84.
               51.  Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening. BMJ
                   2002;325:157-60.
               52.  Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab
                   2003;88:2393-8.
               53.  Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet
                   Gynecol 1999;94:978-84.
               54.  IA Greer. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;10:1258-65.
               55.  Redman CW, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol
                   1999;180:499-506.
               56.  Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes
                   1991;40:18-24.
               57.  Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic? Clin Sci (Lond) 1999;96:421-5.
               58.  Redman CW, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol
                   1999;180:499-506.
               59.  Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G. Prepregnancy cardiovascular risk factors as predictors of pre-
                   eclampsia: population based cohort study. BMJ 2007;335:978.
               60.  Romundstad PR, Magnussen EB, Davey Smith G, Vatten LJ. Hypertension in pregnancy and later cardiovascular disease: common
                   antecedents? Circulation 2010;122:579-84.
               61.  Cassidy-Bushrow AE, Bielak LE, Rule AD, Sheedy PF, Turner ST, et al. Hypertension during pregnancy is associated with coronary
                   artery calcium independent of renal function. J Womens Health (Larchmt) 2009;18:1709-16.
               62.  Feig DS, Shah BR, Lipscombe LL, Wu CF, Ray JG, et al. Preeclampsia as a risk factor for diabetes: a population based cohort study.
                   PLoSMed 2013;10.
               63.  Akhter T, Wikström AK, Larsson M. Individual common carotid artery wall layer dimensions, but not carotid intima-media thickness,
                   indicate increased cardiovascular risk in women with preeclampsia. Circ Cardiovasc Imaging 2013;6:762-8.
   186   187   188   189   190   191   192   193   194   195   196